by Tim Olmstead | Oct 1, 2020 | Uncategorized
Insights Our Blog October 1, 2020 Alinea’s Jamila Seibel Reflects on Fulfilling Medical Mission Trip to Nepal Authors: Jamila Seibel, PharmD, Consultant In 2017 I was invited to participate in a trip of a lifetime: a medical mission to Dharapani, a rural village...
by Tim Olmstead | Jul 16, 2018 | Uncategorized
Insights Our Blog July 16, 2016 340B Program Transparency, Calls for Reform a Dominating Theme of the 2018 340B Coalition Summer Conference Authors: Curtis Frazier, 340B Subject Matter Expert Once again, the 340B Coalition Summer Conference did not disappoint! With...
by Tim Olmstead | Jun 11, 2018 | Uncategorized
Insights Our Blog June 11, 2018 Five 340B HRSA Audit Review Elements to be Prepared for Authors: Tim Olmstead, Managing Partner It has now been six years since HRSA first started conducting 340B audits on a regular basis. If you are reading this as a covered entity,...
by Tim Olmstead | May 1, 2017 | Uncategorized
Insights Our Blog May 1, 2017 A Recap of Important 2017 340B Developments Author: Jamila Seibel, PharmD, Consultant Can you believe it? With 5 months into the new year, we are almost halfway through 2017 already! While postponement of the 340B “mega guidance”...
by Tim Olmstead | Apr 17, 2017 | Uncategorized
Insights Our Blog April 17, 2017 GAO340B Contract Pharmacy Study: Time for Covered Entities to Take a Close Look at Contract Pharmacy Arrangements Author: Russ Barron, Associate Director With the Government Accountability Office’s (“GAO”) study of 340B contract...
by Tim Olmstead | Jan 23, 2017 | Uncategorized
Insights Our Blog January 23, 2017 Alinea’s 5 Key 340B Observations For 2017: HRSA Audits Intensify, Legislative Questions Linger, and New 340B Requirements Take Hold on April 1 Author: Tim Olmstead, Managing Partner There is no doubt that 2017 will be a year packed...
